A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
Target Therapies Resistance Molecular Profiling in Patients With Neoplastic Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of Epacadostat and Nivolumab in Combination With Immune Therapies in Participants With Advanced or Metastatic Malignancies (ECHO-208)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
AZD1775 Continued Access Study to Assess Safety and Tolerability for Patients Enrolled in AZD1775 Clinical Pharmacology Studies
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients
- Status
- UNKNOWN
- Phase
- N/A
A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)
- Status
- COMPLETED
- Phase
- PHASE1
Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Safety and Tolerability Study of Pemigatinib in Japanese Subjects With Advanced Malignancies - (FIGHT-102)
- Status
- COMPLETED
- Phase
- PHASE1
M3541 in Combination With Radiotherapy in Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Phase I Study of KN035 in Chinese Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating MM-310 in Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
- Status
- SUSPENDED
- Phase
- PHASE1
ODM-207 in Patients With Advance Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2